Literature DB >> 1973788

Early US experience with anti-HCV kit in blood donors.

J E Menitove, W A Richards, M Destree.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 1973788     DOI: 10.1016/0140-6736(90)91767-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Evaluation of hepatitis C virus kits.

Authors:  R K Chaudhary; S Frenette; T Mo
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

3.  High rate of false positives in blood donor screening for antibodies to hepatitis C virus. Cause of underestimation of virus transmission rate?

Authors:  W Prohaska; C Wolff; E Lechler; K Kleesiek
Journal:  Klin Wochenschr       Date:  1991-05-03

4.  The epidemiology of hepatitis C in Turkey.

Authors:  D L Thomas; R W Mahley; S Badur; E Palaoglu; T C Quinn
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

5.  Virological features of hepatitis C virus infection in hemodialysis patients.

Authors:  E Silini; F Bono; A Cerino; V Piazza; E Solcia; M U Mondelli
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

6.  Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein.

Authors:  B Hosein; C T Fang; M A Popovsky; J Ye; M Zhang; C Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

7.  Investigation of sera reactive to hepatitis C virus by second-generation enzyme immunoassay.

Authors:  E H Frost
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.